Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib: a consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension - Bringhen, Sara; Goldschmidt, Hartmut (Journal of internal medicine, 2019)
First published 06 February 2019